REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Reddy's Laboratories Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dr. Reddy's Laboratories Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dr. Reddy's Laboratories Sas is an enterprise based in Colombia. Its main office is in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on November 04, 2014. There are currently 40 (2024) people employed by Dr. Reddy's Laboratories Sas. The latest financial highlights indicate a net sales revenue increase of 32.42% in 2023. During that time, Dr. Reddy's Laboratories Sas’s total assets decreased by 1.23%.

Headquarters
Cra 7 No 155 C -30 Ofc 2805
Bogota D.C.; Bogota D.C; Postal Code: 1007

Contact Details: Purchase the Dr. Reddy's Laboratories Sas report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Reddy's Laboratories Sas report to view the information.
Outstanding Shares:
Purchase the Dr. Reddy's Laboratories Sas report to view the information.
Incorporation Date:
November 04, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Dr. Reddy's Laboratories Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
32.42%
Total operating revenue
33.22%
Operating profit (EBIT)
-47.9%
EBITDA
-34.83%
Net Profit (Loss) for the Period
N/A
Total assets
-1.23%
Total equity
726.91%
Operating Profit Margin (ROS)
-1.67%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
65.21%
Quick Ratio
0.09%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?